These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [5-aminosalicylic acid in the treatment of ulcerative colitis and Crohn's disease]. Moum B. Tidsskr Nor Laegeforen; 2003 Sep 25; 123(18):2565-7. PubMed ID: 14714043 [Abstract] [Full Text] [Related]
29. Mesalamine in the treatment of mild to moderate active Crohn's ileitis: results of a randomized, multicenter trial. Prantera C, Cottone M, Pallone F, Annese V, Franzè A, Cerutti R, Bianchi Porro G. Gastroenterology; 1999 Mar 25; 116(3):521-6. PubMed ID: 10029609 [Abstract] [Full Text] [Related]
30. Budesonide versus mesalamine for maintaining remission in patients refusing other immunomodulators for steroid-dependent Crohn's disease. Mantzaris GJ, Petraki K, Sfakianakis M, Archavlis E, Christidou A, Chadio-Iordanides H, Triadaphyllou G. Clin Gastroenterol Hepatol; 2003 Mar 25; 1(2):122-8. PubMed ID: 15017504 [Abstract] [Full Text] [Related]
32. Mesalazine for the treatment of inflammatory bowel disease. Criscuoli V, Modesto I, Orlando A, Cottone M. Expert Opin Pharmacother; 2013 Aug 25; 14(12):1669-78. PubMed ID: 23767798 [Abstract] [Full Text] [Related]